glp-1 drug liraglutide may protect against dementia Promising New Data Support GLP-1s for Prevention Generic Liraglutide (Victoza) Becomes First

Study authors reported that IGF-1 in the older men increased by 25% with the highest dose, reaching levels observed in the untreated younger individuals

Research Background FOXO4-DRI has been studied in preclinical senescence research for its proposed ability to selectively induce apoptosis in senescent cells by disrupting FOXO4-p53 binding

The injections can serve as a powerful jumpstart that provides the energy, motivation, and metabolic support needed to establish new routines

ALCAR has a place in the treatment of vascular cognitive impairment (VCI) as was demonstrated in a recent DBRPCT (Young et al

Interestingly for Al + SeNP-MT 13 was discriminated both for O 2 and H 2 O 2 where Al + SeNP-MT 3 behaved contrarily to increase the stain intensity